| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.894041 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107173624 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 201126t20202020onc ob f00| 0 eng d |
|---|
| 020 | |a9780660367521 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-355/2020E-PDF |
|---|
| 245 | 00|aGuidance for market authorization requirements for COVID-19 vaccines. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada,|c2020. |
|---|
| 264 | 4|c©2020 |
|---|
| 300 | |a1 online resource (15 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Ligne directrice sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19. |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references (pages 13-15). |
|---|
| 650 | 0|aCOVID-19 (Disease)|xVaccination|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tLigne directrice sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19.|w(CaOODSP)9.894043 |
|---|
| 794 | |tGuidance for market authorization requirements for COVID-19 vaccines.|w(CaOODSP)9.898409 |
|---|
| 856 | 40|qPDF|s766 KB|uhttps://publications.gc.ca/collections/collection_2021/sc-hc/H14-355-2020-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/guidance-market-authorization-vaccines.html |
|---|
| 986 | |aPub.: 200315 |
|---|